Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
- 1 December 2006
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 50 (6) , 1194-1207
- https://doi.org/10.1016/j.eururo.2006.05.025
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Update on oral treatments for male erectile dysfunctionJournal of the European Academy of Dermatology and Venereology, 2004
- Efficacy of Sildenafil in the Treatment of Female Sexual Dysfunction Due to Multiple SclerosisJournal of Urology, 2004
- Phosphodiesterase 5 Inhibitors in Rapid EjaculationDrugs, 2004
- Genes and erectile functionCurrent Opinion in Urology, 2003
- Cyclic nucleotide phosphodiesterasesJournal of Allergy and Clinical Immunology, 2001
- Urological Aspects of Female Sexual DysfunctionUrologia Internationalis, 2000
- Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific PhosphodiesteraseBiochemical and Biophysical Research Communications, 1998
- THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVOJournal of Urology, 1998
- Cyclic nucleotide phosphodiesterase in human cavernous smooth muscleWorld Journal of Urology, 1997
- Die Phosphodiesterase-Isoenzyme des humanen Corpus cavernosum penis und deren funktionelle BedeutungAktuelle Urologie, 1995